pubmed-article:16753872 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16753872 | lifeskim:mentions | umls-concept:C0019829 | lld:lifeskim |
pubmed-article:16753872 | lifeskim:mentions | umls-concept:C0035020 | lld:lifeskim |
pubmed-article:16753872 | lifeskim:mentions | umls-concept:C0301872 | lld:lifeskim |
pubmed-article:16753872 | lifeskim:mentions | umls-concept:C0205359 | lld:lifeskim |
pubmed-article:16753872 | lifeskim:mentions | umls-concept:C0332282 | lld:lifeskim |
pubmed-article:16753872 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
pubmed-article:16753872 | lifeskim:mentions | umls-concept:C2699488 | lld:lifeskim |
pubmed-article:16753872 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:16753872 | pubmed:dateCreated | 2006-6-6 | lld:pubmed |
pubmed-article:16753872 | pubmed:abstractText | To our knowledge, there has been no report of spontaneous regression in a non-immunocompromised adult with classical Hodgkin's lymphoma (HL) in the absence of chemotherapy. We describe spontaneous regression and subsequent relapse of Epstein - Barr virus (EBV)-positive HL in an otherwise healthy male adult. The clinical course was associated with an increase in regulatory T-cell markers within the peripheral blood and diseased lymph node at the time of relapse and with a concomitant reduction in cellular immunity against relevant EBV latent membrane protein tumor-associated antigens. Our findings are in keeping with previous observations that implicate impaired cellular immunity in the immunopathogenesis of EBV-positive HL. | lld:pubmed |
pubmed-article:16753872 | pubmed:language | eng | lld:pubmed |
pubmed-article:16753872 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16753872 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16753872 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16753872 | pubmed:month | May | lld:pubmed |
pubmed-article:16753872 | pubmed:issn | 1042-8194 | lld:pubmed |
pubmed-article:16753872 | pubmed:author | pubmed-author:WilsonW MWM | lld:pubmed |
pubmed-article:16753872 | pubmed:author | pubmed-author:GriggA PAP | lld:pubmed |
pubmed-article:16753872 | pubmed:author | pubmed-author:GandhiM KMK | lld:pubmed |
pubmed-article:16753872 | pubmed:author | pubmed-author:DuaUU | lld:pubmed |
pubmed-article:16753872 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16753872 | pubmed:volume | 47 | lld:pubmed |
pubmed-article:16753872 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16753872 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16753872 | pubmed:pagination | 871-6 | lld:pubmed |
pubmed-article:16753872 | pubmed:meshHeading | pubmed-meshheading:16753872... | lld:pubmed |
pubmed-article:16753872 | pubmed:meshHeading | pubmed-meshheading:16753872... | lld:pubmed |
pubmed-article:16753872 | pubmed:meshHeading | pubmed-meshheading:16753872... | lld:pubmed |
pubmed-article:16753872 | pubmed:meshHeading | pubmed-meshheading:16753872... | lld:pubmed |
pubmed-article:16753872 | pubmed:meshHeading | pubmed-meshheading:16753872... | lld:pubmed |
pubmed-article:16753872 | pubmed:meshHeading | pubmed-meshheading:16753872... | lld:pubmed |
pubmed-article:16753872 | pubmed:meshHeading | pubmed-meshheading:16753872... | lld:pubmed |
pubmed-article:16753872 | pubmed:meshHeading | pubmed-meshheading:16753872... | lld:pubmed |
pubmed-article:16753872 | pubmed:meshHeading | pubmed-meshheading:16753872... | lld:pubmed |
pubmed-article:16753872 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16753872 | pubmed:articleTitle | Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma. | lld:pubmed |
pubmed-article:16753872 | pubmed:affiliation | Department of Clinical Haematology, Royal Melbourne Hospital, Parkville, Victoria, Australia. | lld:pubmed |
pubmed-article:16753872 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16753872 | pubmed:publicationType | Case Reports | lld:pubmed |